With corresponding skin changes, proof of Anti-SCL70 antibodies gives support to the suspected diagnosis of scleroderma; U1-RNP-antibodies support the diagnosis of a mixed connective tissue disease (MCTD; Sharp Syndrome). Here, SNRNP70 is linked to mixed connective tissue disease.